Assistant Professor, Department of Public Health, Faculty Of Medicine, Ankara Yıldırım Beyazıt University, and Project Manager, Research for Health in Conflict (R4HC-MENA) Programme, Department of Pediatric Oncology, Hacettepe University, Ankara, TURKEY.
Indian J Med Ethics. 2022 Jul-Sep;VII(3):237-239. doi: 10.20529/IJME.2022.010. Epub 2022 Feb 5.
Vaccine inequality is the biggest obstacle to curbing the Covid-19 pandemic and accelerating socio-economic recovery in the developing countries. Many people, including myself, living in developing countries, were initially inoculated with the WHO-approved vaccines unwelcome to developed countries, such as Sinovac. Presently, governments in developing countries are offering the third and fourth doses of mRNA vaccines to facilitate cross-border travel. This creates a devastating burden on ongoing Covid-19 vaccination in developing countries, increasing the injustice and inequality between the developed and developing countries. Here, I share my thoughts as a public health specialist while I was receiving the fourth dose of the Covid-19 vaccine to fulfil travel requirements.
疫苗不平等是遏制新冠疫情大流行和加速发展中国家社会经济复苏的最大障碍。包括我在内的许多生活在发展中国家的人最初接种的是世卫组织批准的、不受发达国家欢迎的疫苗，如科兴疫苗。目前，发展中国家政府正在为民众提供第三针和第四针 mRNA 疫苗，以促进跨境旅行。这给发展中国家正在进行的新冠疫苗接种工作带来了毁灭性的负担，加剧了发达国家和发展中国家之间的不公平和不平等。在此，我分享一下自己作为一名公共卫生专家的想法，我正在接种第四针新冠疫苗，以满足旅行要求。
